3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
81
Breast Neoplasms
10
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
4
Bulbo-Spinal Atrophy, X-Linked
4
Neoplasms
3
Salivary Gland Neoplasms
2
Osteoporosis
2
Thrombocytosis
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Stage I Prostate Adenocarcinoma
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Prostate Adenocarcinoma
1
Primary Myelofibrosis
1
Primary Dysautonomias
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Castrate Metastatic Prostate Cancer
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metabolic Diseases
1
Interventions
Metformin
7
Progesterone
6
Spironolactone
4
drospirenone and ethinyl estradiol combination
3
Inositol
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
Sugars
2
Folic Acid
2
Flutamide
2
Estradiol
2
Cyproterone Acetate
2
maltodextrin
1
bicalutamide
1
Yoga
1
Waist-Hip Ratio
1
Waist Circumference
1
Ultrasonography
1
Topiramate
1
Time
1
Thioctic Acid
1
Sodium Salicylate
1
Sex Characteristics
1
Physical Examination
1
Phlebotomy
1
Phenotype
1
Ovidrel
1
Magnesium
1
Lactalbumin
1
Inulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hyperandrogenism
×
bicalutamide
×
Clear all
NCT05647356
2022-12-12
REFUEL PCOS
Royal College of Surgeons, Ireland
Phase NA
Unknown
16 enrolled